FLORINALE ELORTA: Open Payments
NPI 1578932026 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,094 in 26 payments from 5 companies in 2025. Trend: 2023 $1,488 · 2024 $971 · 2025 $1,094
Food & beverage: $1,094
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $598 |
| Janssen Biotech, Inc. | 3 | $311 |
| Aimmune Therapeutics, Inc. | 1 | $125 |
| Celltrion USA Inc. | 1 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: TREMFYA, RINVOQ, SKYRIZI, ZENPEP, VEGZELMA, ENTYVIO.
Industry payments across CA — which companies pay providers there.
